News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cardama Alfonso Quintas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 109,459 shares
@ $0
Disposed/sold 70,649 options to buy
@ $0.97, valued at
$68.5k
Disposed/sold 31,582 options to buy
@ $0.74, valued at
$23.4k
Disposed/sold 42,346 options to buy
@ $0.74, valued at
$31.3k
Disposed/sold 90,720 options to buy
@ $5.88, valued at
$533.4k
Disposed/sold 114,700 options to buy
@ $5.21, valued at
$597.6k
Disposed/sold 11,775 restricted stock units
@ $0
Disposed/sold 1,409 restricted stock units
@ $0
Disposed/sold 6,489 restricted stock units
@ $0
Disposed/sold 9,549 restricted stock units
@ $0 |
|
| 12/19/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 70,649 options to buy
@ $0.97, valued at
$68.5k
Granted 11,775 options to buy
@ $0 |
|
| 12/13/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 4,461 shares
@ $1.13, valued at
$5k
Sold 4,586 shares
@ $1.099, valued at
$5k
Sold 4,752 shares
@ $1.061, valued at
$5k
|
|
| 12/09/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 3,928 shares
@ $1.283, valued at
$5k
Sold 4,014 shares
@ $1.256, valued at
$5k
|
|
| 12/07/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 3,686 shares
@ $1.37, valued at
$5k
Sold 3,778 shares
@ $1.334, valued at
$5k
|
|
| 12/05/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 3,636 shares
@ $1.39, valued at
$5.1k
Exercised 69,025 restricted stock units
@ $0
Exercised 17,545 restricted stock units
@ $0
Exercised 8,815 restricted stock units
@ $0 |
|
| 11/18/2022 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Disposed/sold 5,799 options to buy
@ $16.11, valued at
$93.4k
Granted 1,933 options to buy
@ $0
Disposed/sold 205,503 options to buy
@ $16.11, valued at
$3.3M
Granted 68,501 options to buy
@ $0
Disposed/sold 3,308 options to buy
@ $16.1, valued at
$53.3k
Granted 1,103 options to buy
@ $0
Disposed/sold 68,792 options to buy
@ $16.1, valued at
$1.1M
Granted 22,931 options to buy
@ $0
Disposed/sold 4,486 options to buy
@ $31.83, valued at
$142.8k
Granted 816 options to buy
@ $0
Disposed/sold 96,514 options to buy
@ $31.83, valued at
$3.1M
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 101,000 options to buy
@ $31.83, valued at
$3.2M
|
|
| 03/27/2020 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 843 shares
@ $12.75, valued at
$10.7k
Granted 1,082 shares
@ $10.1, valued at
$10.9k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 211,302 options to buy
@ $16.11, valued at
$3.4M
|
|
| 02/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|